Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Tower Resources, Buccaneer Energy, Light Science Technologies, Eco Buildings, Frontier IP, ImmuPharma - Small Cap Snapshot

Tower Resources, Buccaneer Energy, Light Science Technologies, Eco Buildings, Frontier IP, ImmuPharma - Small Cap Snapshot

Tower Resources PLC (AIM:TRP, FRA:ULF1) has raised £400,000 to bolster working capital while it waits on government approvals in Namibia and Cameroon. The company says both farm-out deals could complete as early as July. Read more

Buccaneer Energy Plc (AIM:BUCE, FRA:LMU1) says its proved reserves rose 18% in an independent review tied to its bank credit facility. The borrowing base was confirmed at $4.45 million, with more growth expected as production ramps up. Read more

Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) has secured up to £1.66 million in orders for its passive fire protection division since April's RLUK Injection acquisition. The company says it's now a vertically integrated business spanning installation and material supply. Read more

Eco Buildings Group PLC (AIM:ECOB, FRA:9ZL0) has started building a second-generation AI-enabled manufacturing line in Albania, the first major use of its recent £2.35 million fundraise. The new line should be operational by the fourth quarter. Watch more

Fieldwork Robotics, backed by Frontier IP Group PLC (LSE:FIPP, FRA:8WT), has picked up a £300,000 investment from SEED Innovations to roll out its soft fruit harvesting robots. Multi-robot fleets could be on farms from 2027 if trials succeed. Read more

ImmuPharma PLC (AIM:IMM, FRA:25I) has flagged new research suggesting its lead drug candidate could help treat glioblastoma, an aggressive brain cancer. The company says its main focus remains autoimmune disease, with this a potential extra application. Read more

Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK